How long does it take for Gliclazide to lower blood sugar levels?

Gliclazide, as a hypoglycemic agent, demonstrates variable glucose-lowering effects among individuals. Generally, the therapeutic response depends on multiple factors including individual differences, severity of the condition, and lifestyle.

Gliclazide belongs to the second-generation sulfonylurea class of medications. Its blood glucose-lowering effect typically begins 6–12 hours after administration and can last up to 24 hours. Generally, most patients may observe a reduction in blood glucose levels within approximately one day of starting treatment. For patients newly diagnosed or with mild type 2 diabetes, a gradual decline in blood glucose levels is usually noticeable within 1–2 weeks after initiating gliclazide therapy.

This does not imply that blood glucose levels will drop immediately in every patient following administration. Each person's physiology differs, and responses to medication can vary accordingly. During treatment, patients should regularly monitor their blood glucose levels and adjust therapy as directed by their physician to achieve optimal glycemic control.

Patients should also maintain dietary control and engage in appropriate physical activity while taking gliclazide to support blood glucose management. Additionally, they should remain vigilant regarding potential adverse effects associated with the medication, such as hypoglycemia, and take appropriate preventive measures.